Anesthesia and respiratory devices include devices used in administering anesthesia during surgery, devices used in respiratory assistance and respiratory function measurement. An Anesthesia mask is used for administering anesthetic gases to a patient through inhalation and active and passive oxygenation. A Laryngeal mask is a frequently-used efficient supraglottic airway device; it maintains a patient’s airway open during anesthesia or unconsciousness. GlobalData uses proprietary data and analytics to provide a comprehensive report on the anesthesia and laryngeal masks market in New Zealand. Buy the latest report here.

In 2022, GlobalData’s Market Model methodology determined that the leading player in the anesthesia and laryngeal masks market in New Zealand was Ambu followed by Cardinal Health, Dragerwerk AG & CoAGa, Intersurgical, Medline Industries, Medtronic, Smiths Medical, Teleflex, Vyaire Medical and Vygon.

Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.

An Anesthesia mask fits over the mouth and nose of the patient. They are made of anti-static silicone, PVC, rubber etc. A Laryngeal Mask consists of an inflatable silicone mask and rubber connecting tube that seals the larynx. It is inserted blindly into the pharynx, forming a low-pressure seal around the laryngeal inlet and allowing gentle positive pressure ventilation. Laryngeal mask was the first effective product to offer major advantages over conventional methods of airway support during surgical or life-saving procedures. These masks can be made up of silicone and polyvinyl chloride (PVC).

The anesthesia and laryngeal masks market in New Zealand can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.

For the latest analysis of the market size anesthesia and laryngeal masks in New Zealand, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.